A review and assessment of proposed rule changes governing 340B programs.
Anthony Zappa, PharmD, MBA
Advertisement
Articles by Anthony Zappa, PharmD, MBA
With continued increases in the US drug spend, the evolution of fully transparent PBM programs has introduced an alternative approach to traditional PBM structures aimed at enhanced utilization and cost control.
Advertisement
Latest Updated Articles
- Is PBM Transparency an Answer to Controlling Rising Drug Costs?
August 20th 2015
- Proposed Rule Changes for 340B Programs: Overview and Impact
October 16th 2015
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure
3
Q&A: Pharmacists' Role in CKD Grows as Finerenone Eyes Label Expansion
4
Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter
5